Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KERNAL-FORTE
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
KERNAL-FORTE is a multi-ingredient nutritional supplement capsule developed by Croise Pharma. It is formulated with a combination of calcitriol, calcium citrate, vitamin K2-7 (menaquinone-7), methylcobalamin, L-methylfolate, pyridoxal 5-phosphate, boron, and omega-3 fatty acids. This combination is designed to support bone health, cardiovascular function, and neurological health, and to address nutritional deficiencies.
- Brand names
- KERNAL-FORTEKERNAL-FORTE Cap.
- Other names
- KERNAL-FORTE Capsule
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on KERNAL-FORTE.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KERNAL-FORTE.